Skip to content

Molecular mechanism of regulating plasma lncRNAs expression level by transcranial alternating current stimulation at 40Hz to improve cognitive function in patients with Alzheimer's disease

Molecular mechanism of regulating plasma lncRNAs expression level by transcranial alternating current stimulation at 40Hz to improve cognitive function in patients with Alzheimer's disease

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500100463
Enrollment
Unknown
Registered
2025-04-09
Start date
2025-04-11
Completion date
Unknown
Last updated
2025-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer disease

Interventions

transcranial alternating current ture stimulation group:transcranial alternating current stimulation
transcranial alternating current sham stimulation group:transcranial alternating current sham stimulation

Sponsors

Affiliated Kangning Hospital of Ningbo University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic and Statistical Manual of Mental Disorders 5th Edition (DSM-5) diagnostic criteria for AD; 2. Age 65-80 years old; 3. Education level above primary school; 4. Can cooperate with the completion of various examinations, scale evaluation and treatment; 5. Signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Have suffered from other neurological diseases (including stroke, Parkinson's disease, epilepsy, etc.); 2. Exclude possible vascular, trauma, medical and other causes of cognitive decline; 3. Have heart, liver, lung, kidney, hematopoietic system and other serious diseases; 4. Other conditions that the investigator judged unsuitable for participation in the study.

Design outcomes

Primary

MeasureTime frame
Alzheimer's Disease Cooperative Study - Activities of Daily Living Scale (ADCS-ADL);Simple Mental State Test Scale (MMSE);The expression level of lncRNA in the whole genome;Alzheimer's Disease Assessment Scale - Cognitive Subscale;

Secondary

MeasureTime frame
Anxiety screen scale (GAD-7);Depression Screening Scale (PHQ-9);

Countries

China

Contacts

Public ContactLi Lian

Affiliated Kangning Hospital of Ningbo University

1539480145@qq.com+86 19857840971

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026